门诊药剂师在阿片类药物使用障碍诊所开药的影响
Journal of the American Pharmacists Association : JAPhA
|April 11, 2024
概括
将门诊药剂师安置在布普伦诺芬诊所中,降低了处方费用,提高了患者满意度. 这一战略有助于克服阿片类药物使用障碍药物获取障碍.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 阿片类药物使用障碍药物至关重要,但面临着获取挑战.
- 将药剂师整合到门诊可以改善药物获取和患者支持.
- 由现场药剂师分发布普伦诺芬可以解决这些障碍.
研究的目的:
- 评估门诊住院药剂师发放布普伦诺芬对慈善护理费用的影响.
- 评估患者对布普伦诺啡诊所现场药剂师的满意度.
- 为了确定药剂师的存在是否会影响处方成本和患者体验.
主要方法:
- 药品发行记录的回顾性分析 (16周药剂师前后的存在).
- 使用独立样本测试对慈善机构收取的平均未覆盖的处方费用进行比较.
- 患者满意度调查评估了询问问题,取处方和遵守药物的可能性.
主要成果:
- 每处方的平均未覆盖成本从55.00美元降至36.97美元 (P = 0.002).
- 增加医疗补助或私人保险后药剂师实施的使用率.
- 报告的患者满意度高,与药剂师和药物接触的可能性增加.
结论:
- 现场药剂师的存在成功地将处方从慈善护理转移到保险覆盖.
- 这使得慈善机构的医疗费用大大降低,平均处方费用也大大降低.
- 药剂师在诊所的整合有效地减少了与药物接入和药物坚持相关的患者障碍.
更多相关视频
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
2.7K
12:20Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
21.2K
相关概念视频
Prescription, Nonprescription and Orphan Drugs
724
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
724
Opioid Analgesics: Synthetic and Semisynthetic Opioids
287
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
287
Drug Abuse and Addiction: Pharmacological Phenomena
469
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
469
Opioid Analgesics: Morphine and Other Natural Cogeners
243
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
243
Analgesia and Pain Management
614
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
614
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134
